Successful prevention of recurrent nasal polyposis by means of systemic low-dose IFN-alpha2a. [electronic resource]
- The Journal of allergy and clinical immunology Jul 2001
- 141 p. digital
Publication Type: Case Reports; Letter
0091-6749
10.1067/mai.2001.116288 doi
Female Humans Interferon alpha-2 Interferon-alpha--administration & dosage Male Middle Aged Nasal Polyps--prevention & control Recombinant Proteins Recurrence